Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2¯ Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group.

Autor: Rastogi, Priya, Buyse, Marc E., Swain, Sandra M., Jacobs, Samuel A., Robidoux, André, Liepman, Marcia K., Pajon, Eduardo R., Dy, Philip A., Posada, Jr, Juan G., Melnik, Marianne K., Piette, Fanny, Geyer, Jr, Charles E., Mamounas, Elfetherios P., Wolmark, Norman
Zdroj: Clinical Breast Cancer; Aug2011, Vol. 11 Issue 4, p228-234, 7p, 1 Diagram, 6 Charts, 1 Graph
Databáze: Complementary Index
Externí odkaz: